Early ADT May Not Up OS in Prostate Cancer With PSA Relapse
Early initiation of continuous androgen-deprivation therapy (ADT) for prostate cancer patients who experience biochemical relapse may not meaningfully improve overall survival, according to new findings. […]
Read more